The neurobiology of pathological gambling and drug addiction: An overview and new findings

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 363, Issue 1507, 2008, Pages 3181-3189

  Potenza, Marc N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Brain imaging; Functional magnetic resonance imaging; Gambling; Impulse control disorder; Impulsivity

Indexed keywords

BEHAVIOR; BRAIN; DRUG USER; GAMBLING; IMAGING METHOD; MENTAL HEALTH; NEUROLOGY; PATHOLOGY;

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADDICTION; BIOLOGICAL MODEL; HUMAN; METABOLISM; NEUROBIOLOGY; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

GAMBLING; HUMANS; MODELS, BIOLOGICAL; NEUROBIOLOGY; NEUROTRANSMITTER AGENTS; SUBSTANCE-RELATED DISORDERS;

EID: 51449085123     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2008.0100     Document Type: Conference Paper

References (87)

1. American Psychiatric Association 1980 Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
2. Arnsten, A. F. 2006 Fundamentals of attention-deficit/ hyperactivity disorder: circuits and pathways. J. Clin. Psychiatry 67(Suppl. 8), 7-12.
3. Bechara, A. 2003 Risky business: emotion, decision-making, and addiction. J. Gambl. Stud. 19, 23-51. (doi:10.1023/A:1021223113233)
4. Belin, D. & Everitt, B. J. 2008 Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57, 432-441. (doi:10.1016/j.neuron.2007.12.019)
5. Bergh, C., Eklund, T., Sodersten, P. & Nordin, C. 1997 Altered dopamine function in pathological gambling. Psychol. Med. 27, 473-475. (doi:10.1017/S0033291796003789)
6. Bjork, J. M., Knutson, B., Fong, G. W., Caggiano, D. M., Bennett, S. M. & Hommer, D. W. 2004 Incentive-elicited brain activation in adolescents: similarities and differences from young adults. J. Neurosci. 24, 1793-1802. (doi:10.1523/JNEUROSCI.4862-03.2004)
7. Blanco, C., Petkova, E., Ibanez, A. & Saiz-Ruiz, J. 2002 A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann. Clin. Psychiatry 14, 9-15.
8. Blumberg, H. P. et al. 2003 A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch. Gen. Psychiatry 60, 601-609. (doi:10.1001/archpsyc.60.6.601)
9. Breiter, H. C. & Rauch, S. L. 1996 Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 4, S127-S138. (doi:10.1006/nimg.1996.0063)
10. Brewer, J. A. & Potenza, M. N. 2008 The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem. Pharmacol. 75, 63-75. (doi:10.1016/j.bcp.2007.06.043)
11. Brewer, J. A., Grant, J. E. & Potenza, M. N. 2008 The treatment of pathological gambling. Addict Disord. Treat. 7, 1-14. (doi:10.1097/ADT.0b013e31803155c2)
12. Bush, G. W., Luu, P. & Posner, M. I. 2000 Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 4, 215-222. (doi:10.1016/S1364-6613(00)01483-2)
13. Chamberlain, S. R. & Sahakian, B. J. 2007 The neuropsychiatry of impulsivity. Curr. Opin. Psychiatry 20, 255-261.
14. Chambers, R. A., Taylor, J. R. & Potenza, M. N. 2003 Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 160, 1041-1052. (doi:10.1176/appi.ajp.160.6.1041)
15. Chambers, R. A., Bickel, W. K. & Potenza, M. N. 2007 A scale-free systems theory of motivation and addiction. Neurosci. Biobehav. Rev. 31, 1017-1045. (doi:10.1016/j.neubiorev.2007.04.005)
16. Childress, A. R., Mozely, P. D., McElgin, W., Fitzgerald, J., Reivich, M. & O'Brien, C. P. 1999 Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 156, 11-18.
17. Clark, L., Bechara, A., Damasio, H., Aitken, M. R. F., Sahakian, B. J. & Robbins, T. W. 2008 Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 131, 1311-1322. (doi:10.1093/brain/awn066)
18. Comings, D. E. 1998 The molecular genetics of pathological gambling. CNS Spectr. 3, 20-37.
19. Coric, V., Kelmendi, B., Pittenger, C., Wasylink, S. & Bloch, M. H. 2007 Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. J. Clin. Psychiatry 68, 170-171.
20. Craig, A. D. 2002 How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci. 3, 655-666. (doi:10.1038/nrn894)
21. Crockford, D. N., Goodyear, B., Edwards, J., Quickfall, J. & el-Guabely, N. 2005 Cue-induced brain activity in pathological gamblers. Biol. Psychiatry 58, 787-795. (doi:10.1016/j.biopsych.2005.04.037)
22. Dalley, J. W. et al. 2007 Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315, 1267-1270. (doi:10.1126/science.1137073)
23. da Silva Lobo, D. S., Vallada, H. P., Knight, J., Martins, S. S., Tavares, H., Gentil, V. & Kennedy, J. L. 2007 Dopamine genes and pathological gambling in discordant sib-pairs. J. Gambl. Stud. 23, 421-433. (doi:10.1007/s10899-007-9060-x)
24. DeCaria, C. M., Begaz, T. & Hollander, E. 1998 Serotonergic and noradrenergic function in pathological gambling. CNS Spectr. 3, 38-47.
25. Elliott, R., Dolan, R. J. & Frith, C. D. 2000 Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb. Cortex 10, 308-317. (doi:10.1093/cercor/10.3.308)
26. Evans, A. H., Lawrence, A. D., Potts, J., Appel, S. & Lees, A. J. 2005 Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65, 1570-1574. (doi:10.1212/01.wnl. 0000184487.72289.f0)
27. Everitt, B. & Robbins, T. W. 2005 Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489. (doi:10.1038/nn1579)
28. Febo, M., Segarra, A. C., Nair, G., Schmidt, K., Duong, T. K. & Ferris, C. F. 2005 The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30, 936-943. (doi:10.1038/sj.npp.1300653)
29. Friston, K. J., Worsleym, K. J., Frackowiak, R. S. J., Mazziotta, J. C. & Evans, A. C. 1994 Assessing the significance of focal activations using their spatial extent. Hum. Brain Mapp. 1, 214-220. (doi:10.1002/hbm.460010207)
30. Garavan, H., Hester, R., Murphy, K., Fassbender, C. & Kelly, C. 2006 Individual differences in the functional anatomy of inhibitory control. Brain Res. 1105, 130-142. (doi:10.1016/j.brainres.2006.03.029)
31. Giovannoni, G., O'Sullivan, J. D., Turner, K., Manson, A. J. & Lees, A. J. L. 2000 Hedonic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J. Neurol. Neurosurg. Psychiatr. 68, 423-428. (doi:10.1136/jnnp.68.4.423)
32. Goldstein, R. Z., Tomasi, D., Rajaram, S., Cottone, L. A., Zhang, L., Maloney, T., Telang, F., Alia-Klein, N. & Volkow, N. D. 2007 Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144, 1153-1159. (doi:10.1016/j.neuroscience.2006.11.024)
33. Goudriaan, A. E., Oosterlaan, J., de Beurs, E. & van den Brink, W. 2004 Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci. Biobehav. Rev. 28, 123-141. (doi:10.1016/j.neubiorev. 2004.03.001)
34. Grant, J. E. & Potenza, M. N. 2006 Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int. Clin. Psychopharmacol. 21, 203-209. (doi:10.1097/00004850-200607000-00002)
35. Grant, J. E., Kim, S. W., Potenza, M. N., Blanco, C., Ibanez, A., Stevens, L. C. & Zaninelli, R. 2003 Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int. Clin. Psychopharmacol. 18, 243-249. (doi:10.1097/00004850-200307000-00007)
36. Grant, J. E., Levine, L., Kim, D. & Potenza, M. N. 2005 Impulse control disorders in adult psychiatric inpatients. Am. J. Psychiatry 162, 2184-2188. (doi:10.1176/appi.ajp.162.11.2184)
37. Grant, J. E., Potenza, M. N., Hollander, E., Cunningham-Williams, R. M., Numinen, T., Smits, G. & Kallio, A. 2006 Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am. J. Psychiatry 163, 303-312. (doi:10.1176/appi.ajp.163.2.303)
38. Grant, J. E., Kim, S. W. & Odlaug, B. L. 2007 N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol. Psychiatry 62, 652-657. (doi:10.1016/j.biopsych.2006.11.021)
39. Grant, J. E., Kim, S. W., Hollander, E. & Potenza, M. N. 2008 Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology. (doi:10.1007/s00213-008-1235- 3)
40. Harvey, J. A. 2004 Cocaine effects on the developing brain. Neurosci. Biobehav. Rev. 27, 751-764. (doi:10.1016/j.neubiorev.2003.11.006)
41. Hollander, E., DeCaria, C. M., Finkell, J. N., Begaz, T., Wong, C. M. & Cartwright, C. 2000 A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol. Psychiatry 47, 813-817. (doi:10.1016/S0006-3223(00)00241-9)
42. Hollander, E., Pallanti, S., Rossi, N. B., Sood, E., Baker, B. R. & Buchsbaum, M. S. 2005 Imaging monetary reward in pathological gamblers. World J. Biol. Psychiatry 6, 113-120. (doi:10.1080/15622970510029768)
43. Hommer, D. 2004 Motivation in alcoholism. In Int. Conf. on Applications of Neuroimaging to Alcoholism, New Haven, CT.
44. Hommer, D., Andreasen, P., Rio, D., Williams, W., Rettimann, U., Monenan, R., Zametkin, A., Rawlings, R. & Linnoila, M. 1997 Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects. J. Neurosci. 17, 2796-2806.
45. Hommer, D. W., Bjork, J. M., Knutson, B., Caggiano, D., Fong, G. & Danube, C. 2004 Motivation in children of alcoholics. Alcohol. Clin. Exp. Res. 28, 22A. (doi:10.1097/00000374-200408002-00412)
46. Jellinger, K. A. 1991 Pathology of Parkinson's disease: pathology other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153-197.
47. Kalivas, P. W. & Volkow, N. D. 2005 The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162, 1403-1413. (doi:10.1176/appi.ajp.162.8.1403)
48. Kim, S. W., Grant, J. E., Adson, D. E. & Shin, Y. C. 2001 Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry 49, 914-921. (doi:10.1016/S0006-3223(01)01079-4)
49. Kim, S. W., Grant, J. E., Adson, D. E., Shin, Y. C. & Zaninelli, R. 2002 A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling disorder. J. Clin. Psychiatry 63, 501-507.
50. Knutson, B., Fong, G. W., Bennett, S. M., Adams, C. M. & Hommer, D. 2003 A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. Neuroimage 18, 263-272. (doi:10.1016/S1053-8119(02)00057-5)
51. Kosten, T. R., Scanley, B. E., Tucker, K. A., Oliveto, A., Prince, C., Sinha, R., Potenza, M. N., Skudlarski, P. & Wexler, B. E. 2006 Cue-induced brain activity changes and relapse in cocaine dependent patients. Neuropsychopharmacology 31, 644-650. (doi:10.1038/sj.npp.1300851)
52. Lang, A. E. & Obeso, J. A. 2004 Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 3, 309-316. (doi:10.1016/S1474-4422(04)00740-9)
53. Linnoila, M., Virkunnen, M., Scheinen, M., Nuutila, A., Rimon, R. & Goodwin, F. 1983 Low cerebrospinal fluid 5 hydroxy indolacetic acid concentrations differentiates impulsive from non impulsive violent behavior. Life Sci. 33, 2609-2614. (doi:10.1016/0024-3205(83)90344-2)
54. Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S., Stern, M. B. & Weintraub, D. 2008 Long-term follow-up of impulse control disorders in Parkinson's disease. Mov. Disord. 23, 75-80. (doi:10.1002/mds.21770)
55. McClure, S., Laibson, D. I., Loewenstein, G. & Cohen, J. D. 2004 Separate neural systems value immediate and delayed monetary rewards. Science 306, 503-507. (doi:10.1126/science.1100907)
56. Menon, V., Adleman, N. E., White, C. D., Glover, G. H. & Reiss, A. L. 2001 Error-related brain activation during a Go/NoGo response inhibition task. Hum. Brain Mapp. 12, 131-143. (doi:10.1002/1097-0193(200103)12: 3〈131::AID-HBM1010〉3.0.CO;2-C)
57. Meyer, G., Hauffa, B. P., Schedlowski, M., Pawluk, C., Stadler, M. A. & Exton, M. S. 2000 Casino gambling increases heart rate and salivary cortisol in regular gamblers. Biol. Psychiatry 48, 948-953. (doi:10.1016/S0006-3223(00)00888-X)
58. Meyer, G., Schwertfeger, J., Exton, M. S., Janssen, O. E., Knapp, W., Stadler, M. A., Schedlowski, M. & Kruger, T. H. 2004 Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 29, 1272-1280. (doi:10.1016/j.psyneuen.2004.03.005)
59. Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M. & Swann, A. C. 2001 Psychiatric aspects of impulsivity. Am. J. Psychiatry 158, 1783-1793. (doi:10.1176/appi.ajp.158.11.1783)
60. Naqvi, N. H., Rudrauf, D., Damasio, H. & Bechara, A. 2007 Damage to the insula disrupts addiction to cigarette smoking. Science 5811, 531-534. (doi:10.1126/science.1135926)
61. Nestler, E. J. 2004 Molecular mechanisms of drug addiction. Neuropharmacology 47, 24-32. (doi:10.1016/j.neuropharm.2004.06. 031)
62. New, A. S. et al. 2002 Blunted prefrontal cortical 18-fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch. Gen. Psychiatry 59, 621-629. (doi:10.1001/archpsyc.59.7.621)
63. Nordin, C. & Eklundh, T. 1999 Altered CSF 5-HIAA disposition in pathologic male gamblers. CNS Spectr. 4, 25-33.
64. Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinate, H., Gelernter, J., Volpicelli, J. R. & O'Brien, C. P. 2003 A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychophamacology 28, 1546-1552. (doi:10.1038/sj.npp.1300219)
65. Pallanti, S., Bernardi, S., Quercioli, L., DeCaria, C. & Hollander, E. 2006 Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr. 11, 955-964.
66. Pearlson, G. D., Shashwath, M., Andre, T., Hylton, J., Potenza, M. N., Worhunsky, P., Andrews, M. & Stevens, M. 2007 Abnormal fMRI activation of reward circuitry in current versus former cocaine abusers. In American College of Neuropsychopharmacology Annual Conference, Boca Raton, FL.
67. Petry, N. M., Stinson, F. S. & Grant, B. F. 2005 Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 66, 564-574.
68. Potenza, M. N. 2006 Should addictive disorders include nonsubstance-related conditions? Addiction 101(Suppl. 1), 142-151. (doi:10.1111/j.1360-0443.2006.01591.x)
69. Potenza, M. N., Steinberg, M. A., McLaughlin, S., Wu, R., Rounsaville, B. J. & O'Malley, S. S. 2001 Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am. J. Psychiatry 158, 1500-1505. (doi:10.1176/appi.ajp.158.9.1500)
70. Potenza, M. N., Leung, H.-C., Blumberg, H. P., Peterson, B. S., Skudlarski, P., Lacadie, C. & Gore, J. C. 2003a An fMRI Stroop study of ventromedial prefrontal cortical function in pathological gamblers. Am. J. Psychiatry 160, 1990-1994. (doi:10.1176/appi.ajp.160.11.1990)
71. Potenza, M. N., Steinberg, M. A., Skudlarski, P., Fulbright, R. K., Lacadie, C., Wilber, M. K., Rounsaville, B. J., Gore, J. C. & Wexler, B. E. 2003b Gambling urges in pathological gamblers: an fMRI study. Arch. Gen. Psychiatry 60, 828-836. (doi:10.1001/archpsyc.60.8.828)
72. Potenza, M. N., Voon, V. & Weintraub, D. 2007 Drug insight: impulse control disorders and dopamine therapies in Parkinson's disease. Nat. Clin. Pract. Neurosci. 3, 664-672. (doi:10.1038/ncpneuro0680)
73. Reuter, J., Raedler, T., Rose, M., Hand, I., Glascher, J. & Buchel, C. 2005 Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat. Neurosci. 8, 147-148. (doi:10.1038/nn1378)
74. Roy, A. et al. 1988 Pathological gambling. A psychobiological study. Arch. Gen. Psychiatry 45, 369-373.
75. Roy, A., de Jong, J. & Linnoila, M. 1989 Extraversion in pathological gamblers: correlates with indexes of noradrenergic function. Arch. Gen. Psychiatry 46, 679-681.
76. Schultz, W., Tremblay, L. & Hollerman, J. R. 2000 Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb. Cortex 10, 272-284. (doi:10.1093/cercor/10.3.272)
77. Shaffer, H. J. & Korn, D. A. 2002 Gambling and related mental disorders: a public health analysis. Annu. Rev. Public Health 23, 171-212. (doi:10.1146/annurev.publhealth.23.100901.140532)
78. Shaffer, H. J., Hall, M. N. & Vander Bilt, J. 1999 Estimating the prevalence of disordered gambling in the United States and Canada: a research synthesis. Am. J. Public Health 89, 1369-1376.
79. Shinohara, K., Yanagisawa, A., Kagota, Y., Gomi, A., Nemoto, K., Moriya, E., Furusawa, E., Furuya, K. & Tersawa, K. 1999 Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Appl. Human Sci. 18, 37-42. (doi:10.2114/jpa.18.37)
80. 18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 20, 413-423. (doi:10.1016/S0893-133X(98) 00111-0)
81. Spanagel, R., Herz, A. & Shippenberg, T. S. 1992 Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl Acad. Sci. USA 89, 2046-2050. (doi:10.1073/pnas.89.6. 2046)
82. Tanabe, J., Thompson, L., Claus, E., Dalwani, M., Hutchison, K. & Banich, M. T. 2007 Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum. Brain Mapp. 28, 1276-1286. (doi:10.1002/hbm.20344)
83. Voon, V., Hassan, K., Zurowski, M., de Souza, M., Thomsen, T., Fox, S., Lang, A. E. & Miyasaki, J. 2006 Prevalence of repetitive and reward-seeking behaviors in Parkinson's disease. Neurology 67, 1254-1257. (doi:10.1212/01.wnl.0000238503.20816.13)
84. Voon, V., Thomsen, T., Miyasaki, J. M., de Souza, M., Shafro, A., Fox, S. H., Duff-Canning, S., Lang, A. E. & Zurowski, M. 2007 Factors associated with dopaminergic drug-related pathological gambling in Parkinson's disease. Arch. Neurol. 64, 212-216. (doi:10.1001/archneur.64.2.212)
85. Weintraub, D., Siderow, A., Potenza, M. N., Goveas, J., Morales, K., Duda, J., Moberg, P. & Stern, M. 2006 Dopamine agonist use is associated with impulse control disorders in Parkinson's disease. Arch. Neurol. 63, 969-973. (doi:10.1001/archneur.63.7.969)
86. Wexler, B. E., Gottschalk, C. H., Fulbright, R. K., Prohovnik, I., Lacadie, C. M., Rounsaville, B. J. & Gore, J. C. 2001 Functional magnetic resonance imaging of cocaine craving. Am. J. Psychiatry 158, 86-95. (doi:10.1176/appi.ajp.158.1.86)
87. Wrase, J. et al. 2007 Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 35, 787-794. (doi:10.1016/j.neuroimage.2006.11.043)